Sino Financial Statements From 2010 to 2025
| SBHMY Stock | USD 8.06 0.00 0.00% |
Check Sino Biopharmaceutica financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Sino Biopharmaceutica's main balance sheet or income statement drivers, such as , as well as many indicators such as . Sino financial statements analysis is a perfect complement when working with Sino Biopharmaceutica Valuation or Volatility modules.
Sino |
Sino Biopharmaceutical Ltd Company Return On Equity Analysis
Sino Biopharmaceutica's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Sino Biopharmaceutica Return On Equity | 0.29 |
Most of Sino Biopharmaceutica's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Sino Biopharmaceutical Ltd is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Based on the latest financial disclosure, Sino Biopharmaceutical Ltd has a Return On Equity of 0.2908. This is 101.21% lower than that of the Healthcare sector and 100.8% lower than that of the Biotechnology industry. The return on equity for all United States stocks is 193.81% lower than that of the firm.
Sino Biopharmaceutical Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Sino Biopharmaceutica's current stock value. Our valuation model uses many indicators to compare Sino Biopharmaceutica value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Sino Biopharmaceutica competition to find correlations between indicators driving Sino Biopharmaceutica's intrinsic value. More Info.Sino Biopharmaceutical Ltd is currently regarded as top stock in return on equity category among its peers. It also is currently regarded as top stock in return on asset category among its peers reporting about 0.16 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Sino Biopharmaceutical Ltd is roughly 6.45 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Sino Biopharmaceutica by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Sino Biopharmaceutica's Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.About Sino Biopharmaceutica Financial Statements
Sino Biopharmaceutica investors use historical fundamental indicators, such as Sino Biopharmaceutica's revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Sino Biopharmaceutica. Please read more on our technical analysis and fundamental analysis pages.
Sino Biopharmaceutical Limited, an investment holding company, operates as a research and development pharmaceutical conglomerate in the Peoples Republic of China. The company was incorporated in 2000 and is headquartered in Wan Chai, Hong Kong. Sino Biopharmaceutica is traded on OTC Exchange in the United States.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Sino Pink Sheet Analysis
When running Sino Biopharmaceutica's price analysis, check to measure Sino Biopharmaceutica's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sino Biopharmaceutica is operating at the current time. Most of Sino Biopharmaceutica's value examination focuses on studying past and present price action to predict the probability of Sino Biopharmaceutica's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sino Biopharmaceutica's price. Additionally, you may evaluate how the addition of Sino Biopharmaceutica to your portfolios can decrease your overall portfolio volatility.